Chinese researchers develop immunotherapeutic agent for colon cancer

Chinese researchers have developed a new immunotherapeutic agent for treating colon cancer, as reported in a recent article in ACS Nano. According to Lu Chunwan from Tianjin University’s School of Life Sciences, the agent enhances T cell effector function upon entering tumor cells, effectively killing them and suppressing colon tumor growth in animal experiments. Importantly, it boosts tumor immunogenicity without significantly affecting normal cells. This development is crucial as colon cancer, known for its long latency period and high mortality rate, poses a significant health threat. Immunotherapy stands out as a promising treatment approach for this condition.

Source – CGTN